Effects of systolic and diastolic blood pressures on incident coronary heart disease and all‐cause death in Chinese women with Type 2 diabetes: The Hong Kong Diabetes Registry
暂无分享,去创建一个
[1] M. Fowler,et al. Clinical Practice Recommendations , 2009, Clinical Diabetes.
[2] Xilin Yang,et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. , 2008, The American journal of cardiology.
[3] A. Kong,et al. Risk factors in V‐shaped risk associations with all‐cause mortality in type 2 diabetes—The Hong Kong Diabetes Registry , 2008, Diabetes/metabolism research and reviews.
[4] D. Niakas,et al. Predictors of health-related quality of life in type II diabetic patients in Greece , 2007, BMC public health.
[5] Xiantao Song,et al. Gender based differences in patients with acute coronary syndrome: findings from Chinese Registry of Acute Coronary Events (CRACE). , 2007, Chinese medical journal.
[6] M. Woodward,et al. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region , 2007, Journal of hypertension.
[7] Song-min Huang,et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[8] A. Arboix,et al. Impact of Female Gender on Prognosis in Type 2 Diabetic Patients with Ischemic Stroke , 2006, European Neurology.
[9] A. Kong,et al. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry , 2006, Diabetologia.
[10] Idf Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[11] L. Groop,et al. Complex Relationship Between Blood Pressure and Mortality in Type 2 Diabetic Patients: A Follow-Up of the Botnia Study , 2006, Hypertension.
[12] Mark Woodward,et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies , 2005, BMJ : British Medical Journal.
[13] J. Rouleau,et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. , 2005, Journal of the American Society of Nephrology : JASN.
[14] J. Meigs,et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. , 2005, Diabetes care.
[15] Seppo Lehto,et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. , 2004, Diabetes care.
[16] Desmond E. Williams,et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. , 2004, American journal of epidemiology.
[17] R. Ozaki,et al. Effect of Angiotensin-Converting Enzyme Inhibition on Survival in 3773 Chinese Type 2 Diabetic Patients , 2004, Hypertension.
[18] E. Barrett-Connor,et al. Women and heart disease: the role of diabetes and hyperglycemia. , 2004, Archives of internal medicine.
[19] G. Hu,et al. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes , 2003, Diabetologia.
[20] R. Hayward,et al. Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care , 2003, Annals of Internal Medicine.
[21] S. Lewington. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .
[22] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[23] Thomas J. Liesegang,et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: The Atherosclerosis Risk in Communities Study. Wong TY, ∗ Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, Klein BEK, Hubbard LD. JAMA 2002;287:1153–1159. , 2002 .
[24] Margaret T May,et al. Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Frank E Harrell Jr, New York: Springer 2001, pp. 568, $79.95. ISBN 0-387-95232-2. , 2002 .
[25] François Gueyffier,et al. J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data , 2002, Annals of Internal Medicine.
[26] T. Heer,et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). , 2002, The American journal of cardiology.
[27] J. Chan,et al. Smoking and diabetes in Chinese men , 2001, Postgraduate medical journal.
[28] Frank E. Harrell,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .
[29] A. Baron,et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. , 2000, Circulation.
[30] R. Schrier,et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.
[31] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[32] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[33] B. Howard,et al. Adverse Effects of Diabetes on Multiple Cardiovascular Disease Risk Factors in Women: The Strong Heart Study , 1998, Diabetes Care.
[34] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[35] I. Wiklund,et al. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. , 1997, Blood pressure.
[36] P. Chu,et al. Use of Antidiabetic and Antihypertensive Drugs in Hospital and Outpatient Settings in Hong Kong , 1996, The Annals of pharmacotherapy.
[37] T. Greene,et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.
[38] P. Home,et al. Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[39] J. Chan,et al. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). , 1993, Postgraduate medical journal.
[40] J. Fuller,et al. Epidemiology of Hypertension in Diabetic Patients and Implications for Treatment , 1991, Diabetes Care.
[41] E. Barrett-Connor,et al. Abnormal Glucose Tolerance and Hypertension , 1990, Diabetes Care.
[42] T. Aizawa,et al. High Blood Pressure as Risk Factor in Diabetic Retinopathy Development in NIDDM Patients , 1987, Diabetes Care.
[43] M. Laakso,et al. Age of Onset and Type of Diabetes , 1985, Diabetes Care.
[44] P. Wahl,et al. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. , 1984, The New England journal of medicine.
[45] K. M. West,et al. A Detailed Study of Risk Factors for Retinopathy and Nephropathy in Diabetes , 1980, Diabetes.
[46] L. Monnier,et al. Influence of Indigestible Fibers on Glucose Tolerance , 1978, Diabetes Care.
[47] M. Fowler. Clinical Practice Recommendations , 2009, Clinical Diabetes.
[48] T. Greene,et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. , 1995, Annals of internal medicine.
[49] A. Krolewski,et al. Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor glycemic control, in patients with type I diabetes. , 1989, Diabete & metabolisme.
[50] G. Duvel. The study group. , 1980 .